Experience

Robert Bitman

    • Nuvation Bio to Combine With Panacea, a Special Purpose Acquisition Company 


    • Billtrust to Combine With South Mountain, a Special Purpose Acquisition Company, at $1.3 Billion Value 


    • Inhibrx – $137 Million IPO 


    • Avidity Biosciences - $289 Million IPO 


    • Arcutis – $192.5 Million Follow-On Offering 


    • Mirati – $1.0 Billion Follow-On Offering